Alx Oncology Holdings (ALXO) Non-Current Assets (2019 - 2026)

Alx Oncology Holdings has reported Non-Current Assets for 8 years, with the latest figure at $32.8 million in Q1 2026.

• Quarterly Non-Current Assets rose 78.38% year-over-year to $32.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.4 million (down 37.36% YoY) and the FY2025 annual result came in at $8.3 million, down 38.02% from the prior year.
• Non-Current Assets rose to $32.8 million in Q1 2026 per ALXO's latest filing, from $8.3 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $53.9 million in Q4 2023 and troughed at $8.3 million in Q4 2025.
• A 5-year average of $29.4 million and a median of $29.2 million in 2022 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 7130.02% in 2022, then slumped 78.08% in 2025.
• Over 5 years, Non-Current Assets stood at $35.5 million in 2022, then soared by 51.73% to $53.9 million in 2023, then sank by 75.09% to $13.4 million in 2024, then plunged by 38.02% to $8.3 million in 2025, then jumped by 293.85% to $32.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $32.8 million, $8.3 million, and $16.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.